CIK 0000948320
- Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760238453
- Phone
- +1 866-351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- 4 Grant or award Chief Acquisition Officer acquired 150,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 125,000 shares (grant or award)
- 4 Grant or award Director acquired 75,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award General Counsel & CCO acquired 150,000 shares (grant or award)
- 4 Grant or award Director acquired 225,000 shares (grant or award)
- 4 Grant or award Director acquired 225,000 shares (grant or award)
- 4 Grant or award COO acquired 150,000 shares (grant or award)
- 4 Open-market buy Director bought 3,945 shares at $2.94 ($11,580)
- 4 Open-market buy Chief Acquisition Officer bought 10,712 shares at $2.92 ($31,279)
- 4 Open-market buy Director bought 68,865 shares at an average $2.48 ($170,480)
- 4 Open-market buy General Counsel & CCO bought 11,500 shares at $2.60 ($29,900)
- 4 Open-market buy Director bought 139,500 shares at an average $2.18 ($303,878)
- 4/A Open-market buy Chief Innovation Officer bought 4,608 shares at $2.17 ($9,999)
- 4 Open-market buy Chief Operating Officer bought 30,000 shares at $2.19 ($65,706)
- 4 Open-market buy CEO bought 50,000 shares at an average $2.09 ($104,625)
- 4 Open-market buy Chief Innovation Officer bought 10,000 shares at $2.17 ($21,700)
- 4 Grant or award Director acquired 75,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
Page 5 of 12 · 230 filings